Otton Krzysztof Roubinek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Otton Krzysztof Roubinek has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Magdalena Jasinska
Faculty of Chemical and Process Engineering, Warsaw University of Technology, Warsaw, Poland
3 shared publications - Alicja Jeżewska
Faculty of Civil and Environmental Engineering, Gdansk University of Technology, 80-233 Gdansk, Poland
1 shared publication Andrzej G. Chmielewski
Institute of Nuclear Chemistry and Nuclear Technology, Warsaw, Poland
1 shared publication- Andrzej Grzegorz Chmielewski
Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warszawa, Poland
1 shared publication - Anna Markowska
Department of Perinatology, Poznań University of Medical Sciences, Polna 33, 60-535 Poznań, Poland
1 shared publication - Anna Remiszewska-Skwarek
Faculty of Civil and Environmental Engineering, Gdansk University of Technology, Narutowicza Street 11/12, 80-233 Gdansk, Poland
1 shared publication
Latest Publications
- Open Access
- 4 October 2025
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 335 (2) , 1667-1673
Investigation of radiotracer types for RTD determination in an aerated CSTR producing Poly(3-hydroxybutyrate)
- 4 October 2025
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 335 (2) , 1667-1673
Open AccessInvestigation of radiotracer types for RTD determination in an aerated CSTR producing Poly(3-hydroxybutyrate)
- Open Access
The Role of Ferulic Acid in Selected Malignant Neoplasms
Ferulic acid (FA) is a polyphenol that is found in plants and fruits. It has a wide range of anticancer properties, including participating in cell apoptosis, inhibiting invasion and angiogenesis, and acting synergistically with standard cytostatic agents in malignant tumors. A range of molecular mechanisms are involved in anticancer activity and include the following ones: activation of cell-cycle-related proteins and enzymes such as p53, p21, Bax, and pro-caspases 3 and 9, reduction of cyclin D1 and E, proapoptotic Bcl-2, MMP-9, and NF-kV, which decrease VEGF, leading to cell cycle arrest at G0/G1 phase and death of cancer cells. Other mechanisms inhibit several pathways: PI3K/AKT/mTOR, Notch, and Wnt, which are associated with downregulation of proliferation, invasion, metastasis, and angiogenesis. FA can induce activation of ROS, leading to DNA damage in cancer cells. In vitro and in vivo studies have demonstrated the significant antitumor activity of FA in breast cancer, particularly when used in combination with cytostatic agents. In vitro studies on cervical cancer cell lines have reported similar anticancer activity of FA. This includes inhibition of cell proliferation and induction of apoptosis by downregulating antiapoptotic proteins. A case-control study conducted in Italy found that men with histologically confirmed prostate cancer had notably lower levels of FA compared to controls. Molecular in vitro studies have suggested that FA may have various effects on the signaling pathways linked to a reduction in the risk of prostate cancer, and it may act in synergy with δ-tocotrienol, which is a derivative of vitamin E. In vivo and in vitro studies on colorectal cancer have demonstrated the effects of FA on the early development of this cancer—inhibition of abnormal crypt foci (ACF-aberrant crypt foci), as well as the reduction in cancer cell viability and apoptosis through molecular changes, mainly a decrease in EGFR expression. The poor water solubility of FA makes it an attractive candidate for use as nanoparticles.
Open AccessThe Role of Ferulic Acid in Selected Malignant Neoplasms
Ferulic acid (FA) is a polyphenol that is found in plants and fruits. It has a wide range of anticancer properties, including participating in cell apoptosis, inhibiting invasion and angiogenesis, and acting synergistically with standard cytostatic agents in malignant tumors. A range of molecular mechanisms are involved in anticancer activity and include the following ones: activation of cell-cycle-related proteins and enzymes such as p53, p21, Bax, and pro-caspases 3 and 9, reduction of cyclin D1 and E, proapoptotic Bcl-2, MMP-9, and NF-kV, which decrease VEGF, leading to cell cycle arrest at G0/G1 phase and death of cancer cells. Other mechanisms inhibit several pathways: PI3K/AKT/mTOR, Notch, and Wnt, which are associated with downregulation of proliferation, invasion, metastasis, and angiogenesis. FA can induce activation of ROS, leading to DNA damage in cancer cells. In vitro and in vivo studies have demonstrated the significant antitumor activity of FA in breast cancer, particularly when used in combination with cytostatic agents. In vitro studies on cervical cancer cell lines have reported similar anticancer activity of FA. This includes inhibition of cell proliferation and induction of apoptosis by downregulating antiapoptotic proteins. A case-control study conducted in Italy found that men with histologically confirmed prostate cancer had notably lower levels of FA compared to controls. Molecular in vitro studies have suggested that FA may have various effects on the signaling pathways linked to a reduction in the risk of prostate cancer, and it may act in synergy with δ-tocotrienol, which is a derivative of vitamin E. In vivo and in vitro studies on colorectal cancer have demonstrated the effects of FA on the early development of this cancer—inhibition of abnormal crypt foci (ACF-aberrant crypt foci), as well as the reduction in cancer cell viability and apoptosis through molecular changes, mainly a decrease in EGFR expression. The poor water solubility of FA makes it an attractive candidate for use as nanoparticles.
- Open Access
The Influence of Low-Temperature Disintegration on the Co-Fermentation Process of Distillation Residue and Waste-Activated Sludge
Innovative low-temperature disintegration (process temperature 55 °C and oxygen concentration 0.2 mg/dm3) can be an economically rational technology to intensifying energy production from renewable sources. The proposed process can achieve a degree of disintegration—under optimal conditions—of about 50%, which is excellent when compared with other methods of feed pre-treatment. The low-temperature disintegration of distillation residue and waste-activated sludge before the co-fermentation process increased biogas production by 30% and methane production by 65% (over a 26 d duration). The obtained results confirm that the low-temperature disintegration method can be effectively used to pre-prepare this type of feed. At the same time, it was discovered that the Gompertz model can be used to mathematically describe the biogas accumulation curves in the methane co-fermentation processes of the tested feeds (the correlation coefficients were higher than 0.98).
Open AccessThe Influence of Low-Temperature Disintegration on the Co-Fermentation Process of Distillation Residue and Waste-Activated Sludge
Innovative low-temperature disintegration (process temperature 55 °C and oxygen concentration 0.2 mg/dm3) can be an economically rational technology to intensifying energy production from renewable sources. The proposed process can achieve a degree of disintegration—under optimal conditions—of about 50%, which is excellent when compared with other methods of feed pre-treatment. The low-temperature disintegration of distillation residue and waste-activated sludge before the co-fermentation process increased biogas production by 30% and methane production by 65% (over a 26 d duration). The obtained results confirm that the low-temperature disintegration method can be effectively used to pre-prepare this type of feed. At the same time, it was discovered that the Gompertz model can be used to mathematically describe the biogas accumulation curves in the methane co-fermentation processes of the tested feeds (the correlation coefficients were higher than 0.98).